D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease

Journal of the American Geriatrics Society

Volumn 53, Issue 10, 2005, Pages 1688-1696

  McDermott, Mary M ^a   Ferrucci, Luigi ^b   Liu, Kiang ^a   Criqui, Michael H ^c   Greenland, Philip ^a   Green, David ^a   Guralnik, Jack M ^b   Ridker, Paul M ^d   Taylor, Lloyd M ^e   Rifai, Nader ^d   Tian, Lu ^a   Zheng, Jane ^a   Pearce, William H ^a   Schneider, Joseph R ^a,f   Vonesh, Ed ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Northwest Hospital   (United States)

Author keywords

C reactive protein; Inflammation; Intermittent claudication; Peripheral vascular disease; Physical functioning

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN;

AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; INFLAMMATION; LEG ARTERY; MAJOR CLINICAL STUDY; MALE; PHYSICAL PERFORMANCE; RACE DIFFERENCE; SEX DIFFERENCE; WALKING;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; COMORBIDITY; DISABILITY EVALUATION; EXERCISE TEST; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; MALE; PHYSICAL FITNESS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM AMYLOID A PROTEIN; STATISTICS;

EID: 30944459212     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53510.x     Document Type: Article

References (46)

1. Cohen HJ, Harris T, Pieper CE. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003;114:180-187.
2. Ferrucci L, Harris TB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639-646.
3. McDermott MM, Greenland P, Liu K et al. Leg symptoms commonly reported by men and women with lower extremity peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 2001;286:1599-1606.
4. McDermott MM, Greenland P, Liu K et al. The ankle brachial index as a measure of leg functioning and physical activity in peripheral arterial disease: The Walking and Leg Circulation Study. Ann Intern Med 2002;136:873-883.
5. McDermott MM, Liu K, Guralnik JM et al. The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease. J Am Geriatr Soc 1998;46:1355-1362.
6. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-2485.
7. McDermott MM, Green D, Greenland P et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003;92:194-199.
8. McDermott MM, Liu K, Greenland P et al. Functional decline in peripheral arterial disease. Associations with the ankle brachial index and leg symptoms. JAMA 2004;292:453-461.
9. McDermott MM, Greenland P, Green D et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003;107:191-198.
10. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
11. Thompson SG, Kienast J, Pyke SD et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635-641.
12. Robson SC, Shephard EG, Kirsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 1994;86:322-326.
13. Rao KMK, Pieper CS, Currie MS et al. Variability of plasma IL-6 and cross-linked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 1994;102:802-805.
14. Shorr AF, Thomas SJ, Alkins SA et al. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 2002;121:1262-1268.
15. Gauldie J, Northemann W, Fey GHO. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 1990;144:3804-3808.
16. Fowkes FGR, Lowe GDO, Housley E et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:84-86.
17. Ridker PM, Hennekens CH, Cerskus A et al. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-2240.
18. Lowe GD, Yarnell JW, Rumley A et al. C-reactive protein, fibrin D-dimer and incident ischemic heart disease in the Speedwell Study: Are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 2001;21:603-610.
19. Ridker PM, Cannon CP, Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-28.
20. Visser M, Pahor M, Taaffe DR et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57A:M326-M332.
21. Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-845.
22. Olin JW. The clinical evaluation and office based detection of peripheral arterial disease. In: Hirsch AT, Olin JW, eds. An Office-Based Approach to the Diagnosis and Treatment of Peripheral Arterial Disease, I. The Epidemiology and Practical Detection of Peripheral Arterial Disease. Am J Med Continuing Education Series. 1998, pp 10-17.
23. McDermott MM, Criqui MH, Liu K et al. The lower ankle brachial index calculated by averaging the dorsalis pedis and posterior tibial arterial pressures is most closely associated with leg functioning in peripheral arterial disease. J Vasc Surg 2000;32:1164-1171.
24. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995;91:1472-1479.
25. Criqui MH, Denenberg JO, Bird CE et al. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996;1:65-71.
26. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-658.
27. Guralnik JM, Fried LP, Simonsick EM et al. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability (NIH Publication no, 95-4009). Bethesda, MD: National Institute on Aging, 1995.
28. Altman R, Alarcon G, Appelrouth D et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-514.
29. Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum 1986;29:1039-1049.
30. Swerts PMJ, Mostert R, Wouters EF. Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther 1990;70:439-442.
31. Simonsick EM, Gardner AW, Poehlman ET. Assessment of physical function and exercise tolerance in older adults: Reproducibility and comparability of five measures. Aging 2000;12:274-280.
32. Greig C, Butler F, Skelton D et al. Treadmill walking in old age may not reproduce the real life situation. J Am Geriatr Soc 1993;41:15-18.
33. Peeters P, Mets T. The six-minute walk as an appropriate exercise test in elderly patients with chronic heart failure. J Gerontol A Biol Sci Med Sci 1996;51A:M147-M151.
34. Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-M94.
35. Guralnik JM, Ferrucci L, Simonsick E et al. Lower extremity function in persons over 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556-561.
36. Montgomery PS, Gardner AW. The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc 1998;46:706-711.
37. Gardner AW, Womack CJ, Sieminski DJ et al. Relationship between free-living daily physical activity and ambulatory measures in older claudicants. Angiology 1998;49:327-337.
38. Guyatt GH, Sullivan MJ, Thompson PJ et al. The six-minute walk. A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
39. Ledue TB, Weiner DL, Sipe JD et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactrve protein, serum amyloid A, and mannose binding protein in human serum. Ann Clin Biochem 1998;35:745-753.
40. Laird N, Ware J, Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
41. Little RJA. Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc 1995;90:1112-1121.
42. Fitzmaurice GM, Laird NM, Shneyer L. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable dropouts. Stat Med 2001;20:1009-1021.
43. Mitch WE, Goldberg AL. Mechanism of muscle wasting: The role of ubiquitin-proteasome pathway. N Engl J Med 1997;335:1897-1905.
44. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991;260:E727-E730.
45. Ferrucci L, Penninx BW, Volpato S et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002;12:1947-1954.
46. Reuben DB, Cheh AI, Harris TB et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002;50:638-644.